WuXi to create $200m investment fund following initial success
The almost-private China-based CDMO (contract development and manufacturing organization) WuXi is looking to reap larger rewards from investing in US and China pharma and biotech firms.
Archives for July 14, 2015
Life ban for founder of fake US drug company with $12m in sales
The founder of a phony pharma company which made $12m importing fake chemo drugs to the US has been banned for life by the US FDA from working with any pharma businesses.
Risk/profit-sharing in clinical trials progresses with Nuvelution launch
With an exclusive board of directors and now some funding, Nuvelution Pharma is looking to get its risk-sharing clinical trial venture for late-stage candidates off the ground and will engage with CROs (contract research organizations) in the near future.
Sandoz closing Mumbai API plant but says it remains committed to India
Sandoz will shutter an Indian API facility in 2016 as part of a manufacturing refocus in the region.